Mersana Therapeutics
Michael Massimo is an experienced professional who currently holds the position of Director of Technical Accounting and SEC Reporting at Mersana Therapeutics. Prior to this, Michael worked at CFGI as a Senior Manager and Manager. With a background in accounting and finance, Michael previously served as an Assurance Manager at EY. Massimo holds a MSA degree in Accounting from Fairfield University.
Mersana Therapeutics
2 followers
Mersana is a biopharmaceutical company specializing in the discovery and development of antibody-drug conjugate (ADC) therapies to treat patients fighting cancer.